168 related articles for article (PubMed ID: 9698365)
1. Identification of a glycosaminoglycan binding surface on human interleukin-8.
Kuschert GS; Hoogewerf AJ; Proudfoot AE; Chung CW; Cooke RM; Hubbard RE; Wells TN; Sanderson PN
Biochemistry; 1998 Aug; 37(32):11193-201. PubMed ID: 9698365
[TBL] [Abstract][Full Text] [Related]
2. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of the glycosaminoglycan binding site of chemokine macrophage-inflammatory protein-1 beta.
Koopmann W; Ediriwickrema C; Krangel MS
J Immunol; 1999 Aug; 163(4):2120-7. PubMed ID: 10438952
[TBL] [Abstract][Full Text] [Related]
4. Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.
McCornack MA; Boren DM; LiWang PJ
Biochemistry; 2004 Aug; 43(31):10090-101. PubMed ID: 15287737
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor (PEDF) binds to glycosaminoglycans: analysis of the binding site.
Alberdi E; Hyde CC; Becerra SP
Biochemistry; 1998 Jul; 37(30):10643-52. PubMed ID: 9692954
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the heparin-binding site of the NC1 domain of collagen XIV by CD and NMR.
Montserret R; Aubert-Foucher E; McLeish MJ; Hill JM; Ficheux D; Jaquinod M; van der Rest M; Deléage G; Penin F
Biochemistry; 1999 May; 38(20):6479-88. PubMed ID: 10350466
[TBL] [Abstract][Full Text] [Related]
7. Investigation of lysine side chain interactions of interleukin-8 with heparin and other glycosaminoglycans studied by a methylation-NMR approach.
Möbius K; Nordsieck K; Pichert A; Samsonov SA; Thomas L; Schiller J; Kalkhof S; Teresa Pisabarro M; Beck-Sickinger AG; Huster D
Glycobiology; 2013 Nov; 23(11):1260-9. PubMed ID: 23982278
[TBL] [Abstract][Full Text] [Related]
8. Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions.
Joseph PR; Mosier PD; Desai UR; Rajarathnam K
Biochem J; 2015 Nov; 472(1):121-33. PubMed ID: 26371375
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulations of CXCL-8 and its interactions with a receptor peptide, heparin fragments, and sulfated linked cyclitols.
Gandhi NS; Mancera RL
J Chem Inf Model; 2011 Feb; 51(2):335-58. PubMed ID: 21299226
[TBL] [Abstract][Full Text] [Related]
10. CXCL1/MGSA Is a Novel Glycosaminoglycan (GAG)-binding Chemokine: STRUCTURAL EVIDENCE FOR TWO DISTINCT NON-OVERLAPPING BINDING DOMAINS.
Sepuru KM; Rajarathnam K
J Biol Chem; 2016 Feb; 291(8):4247-55. PubMed ID: 26721883
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.
Zhao B; Liwang PJ
Biochemistry; 2010 Aug; 49(33):7012-22. PubMed ID: 20712376
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
Katancik JA; Sharma A; de Nardin E
Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
[TBL] [Abstract][Full Text] [Related]
13. Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.
Laurence JS; Blanpain C; De Leener A; Parmentier M; LiWang PJ
Biochemistry; 2001 Apr; 40(16):4990-9. PubMed ID: 11305915
[TBL] [Abstract][Full Text] [Related]
14. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
Gerber N; Lowman H; Artis DR; Eigenbrot C
Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance solution structure of truncated human GRObeta [5-73] and its structural comparison with CXC chemokine family members GROalpha and IL-8.
Qian YQ; Johanson KO; McDevitt P
J Mol Biol; 1999 Dec; 294(5):1065-72. PubMed ID: 10600366
[TBL] [Abstract][Full Text] [Related]
16. The oligomeric structure of vaccinia viral envelope protein A27L is essential for binding to heparin and heparan sulfates on cell surfaces: a structural and functional approach using site-specific mutagenesis.
Ho Y; Hsiao JC; Yang MH; Chung CS; Peng YC; Lin TH; Chang W; Tzou DL
J Mol Biol; 2005 Jun; 349(5):1060-71. PubMed ID: 15913650
[TBL] [Abstract][Full Text] [Related]
17. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.
Goger B; Halden Y; Rek A; Mösl R; Pye D; Gallagher J; Kungl AJ
Biochemistry; 2002 Feb; 41(5):1640-6. PubMed ID: 11814358
[TBL] [Abstract][Full Text] [Related]
18. Glycosaminoglycan binding properties of the myxoma virus CC-chemokine inhibitor, M-T1.
Seet BT; Barrett J; Robichaud J; Shilton B; Singh R; McFadden G
J Biol Chem; 2001 Aug; 276(32):30504-13. PubMed ID: 11369757
[TBL] [Abstract][Full Text] [Related]
19. Differential binding of chemokines to glycosaminoglycan subpopulations.
Witt DP; Lander AD
Curr Biol; 1994 May; 4(5):394-400. PubMed ID: 7922353
[TBL] [Abstract][Full Text] [Related]
20. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses.
Coombe DR; Stevenson SM; Kinnear BF; Gandhi NS; Mancera RL; Osmond RI; Kett WC
Biochemistry; 2008 Apr; 47(17):4863-75. PubMed ID: 18327914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
